Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma

Journal of the American College of Surgeons

Volumn 185, Issue 4, 1997, Pages 415-421

  Ikeguchi, Masahide ^a   Saito, Hiroaki ^a   Katano, Kuniyuki ^a   Tsujitani, Shunichi ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645899302     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(01)00947-4     Document Type: Article

References (22)

1. Finlay CA, Hinds PW, and Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989;57:1083–1093.
2. Chen PW, Chen Y, Bookstein R, and Lee WH. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990;250:1576–1580.
3. Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912–915.
4. Symonds H, Krall L, Remington L, et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994;78:703–711.
5. Harris CC. p53: at the crossroad of molecular carcinogenesis and risk assessment. Science 1993;262:1980–1981.
6. Levine AJ, Momand J, and Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453–456.
7. Nishioka H, Hiasa Y, and Hayashi I. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings. Oncology 1993;50:426–429.
8. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710–1715.
9. Mandard A-M, Dalibard F, Mandard J-C, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680–2686.
10. Sugamura K, Makino M, Shirai H, et al. Enhanced induction of apoptosis of human gastric carcinoma cells after properative treatment with 5-fluorouracil. Cancer 1997;79:12–17.
11. Japanese Society for Esophageal Disease. Guidelines for the Clinical and Pathological Studies on Carcinoma of the Esophagus. 8th ed. Tokyo: Kanehara: 1992.
12. Hsu SM, Raine L, and Fanger H. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–580.
13. Kawai K, Serizawa A, Hamana T. and Tsutsumi Y. Heat-induced antigen retrieval of proliferating cell nuclear antigen and p53 protein in formalin-fixed, paraffin-embedded sections. Pathol Int 1994;44:759–764.
14. Sarbia M, Porschen R, Borchard F, et al. p53 Protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994;74:2218–2223.
15. Kawamura T, Goseki N, Koike M, et al. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer 1996;77:843–849.
16. Thor AD, Moore DH II, Edgerton SM, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer. J Natl Cancer Inst 1992;84:845–855.
17. Joypaul BV, Hopwood D, Newman EL, et al. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994; 69:943–946.
18. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778–2784.
19. Coggi G, Bosari S, Roncalli M, et al. p53 Protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997;79:425–432.
20. Kanda Y, Nishiyama Y, Shimada Y, et al. Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int J Cancer 1994;58:291–297.
21. Ikeguchi M, Katano K, Oka A, et al. Number of argyrophilic nucleolar organizer regions is a good indicator of lymph node metastasis in patients with esophageal carcinoma. Langenbecks Arch Chir 1995;380:197–202.
22. Ikeguchi M, Katano K, Oka A, et al. Are argyrophilic nucleolar organizer regions good prognostic indicators of survival of patients with esophageal cancer with lymph node metastasis? J Surg Oncol 1996;62:201–206.